Daniel Gaudry

Daniel Gaudry currently serves as an Advisor to the Board of the International Alliance for Biological Standardization (IABS), where he continues to leverage his extensive expertise in regulatory science, vaccine development, and biopharmaceuticals. His current role involves providing strategic guidance on key initiatives aimed at harmonizing global standards for biologicals, including vaccines and biotherapeutics. Daniel's deep understanding of infectious diseases, immunology, and microbiology informs his contributions to advancing scientific and medical standards that underpin the approval processes for life-saving biological products worldwide.

Throughout his tenure at IABS, Daniel has been instrumental in fostering international collaboration among regulators, industry stakeholders, and scientific experts. His involvement in key projects has included the development of standardized assays for vaccine potency, the harmonization of regulatory pathways for biopharmaceuticals, and initiatives to improve the safety and efficacy assessment of biologicals. His insights have helped shape policies that streamline clinical development and facilitate timely access to innovative vaccines and therapies.

With a background rooted in veterinary medicine and extensive experience in the pharmaceutical industry, Daniel Gaudry’s expertise spans vaccine technology, infectious disease control, and clinical development. His leadership at IABS reflects a commitment to advancing regulatory science and ensuring the global availability of high-quality biological products. As an Advisor to the Board, he continues to play a pivotal role in guiding the organization’s strategic direction, emphasizing scientific excellence, regulatory harmonization, and the promotion of public health through innovative biological standards.